Salesforce Rises on Earnings Beat, Growing Cloud Demand: What Wall Street's Saying


$91.31's average target is 4.06% above currents $87.75 stock price.

A number of other analysts have also recently weighed in on CRM.

John Roos, director of Salesforce Com Inc, in an insider legal trading deal unloaded some 194 shares whose worth is estimated to be $17,053 at average stock price of $87.9. The stock is expected to report revenue as high as $2.57B and as low as $2.45B per share. Wedbush reissued an "outperform" rating and set a $102.00 price target (down previously from $105.00) on shares of, a research report on Monday. The company's quick move to render cloud services across all its products has allowed it to capture the leading market share in the CRM space. The stock has "Outperform" rating by Macquarie Research on Tuesday, April 26.

The company's expected revenue in the current quarter to be 2.48 Billion, seeing a projected current quarter growth of 29.2%, and per annum growth estimates over the next 5 year period of around 28.32%. Looking at the stock's movement on the chart,, inc. recorded a 52-week high of $90.28.

Based on current stock levels,, inc. shares are trading -1.82% off of the 50-day high and 10.11% away from the 50-day low.

Even though rivals are targeting Salesforce's stronghold in customer-relationship management, the company said it is able to grab significant pieces of new business in the growing field. This is an increase of 165% compared to the typical daily volume of 7,630 call options. That's compared to consensus estimates for earnings of $1.29 per share and $10.19 billion, respectively. During the same quarter past year, the company earned $0.24 EPS. The stock was purchased at an average price of $81.68 per share, with a total value of $99,976.32. On average, equities analysts anticipate that, inc. will post $1.29 earnings per share for the current year.

Commenting on, inc. (NYSE:CRM) earned "Hold" rating by TheStreet on Saturday, August 22.

TRADEMARK VIOLATION NOTICE: This news story was published by Sports Perspectives and is the sole property of of Sports Perspectives. Presently, John Roos owns 16,647 shares which make up precisely 0.00% of the Company's market cap (share price times the number of shares outstanding). Also, Chairman Marc Benioff sold 10,000 shares of the firm's stock in a transaction on Tuesday, February 21st. Following the completion of the sale, the chairman now owns 34,195,300 shares in the company, valued at approximately $2,804,014,600. The disclosure for this purchase can be found here. The stock has been active on the tape, now trading at $87.75, down from yesterday's close by -0.10%. Price to sales ratio was 14.10 while 73.10% of stock was owned by Institutional investors.

Several large investors have recently made changes to their positions in the company.

The firm termed the company's first-quarter results as excellent and noted that the company raised its guidance for the third straight quarter. King Luther Capital Management Corp increased its stake in shares of, 1.3% in the first quarter. Total cash, cash equivalents and marketable securities finished the quarter at $3.22 billion. Comparable store sales increased 1.0% in the quarter. About shares traded. Heat Biologics Inc (NASDAQ:HTBX) has risen 6.00% since April 19, 2017 and is uptrending. (CRM) is a good investment, however if the market is weaker then it could suggest that the shares are undervalued. The correct version of this news story can be read at The Company focuses on cloud, mobile, social, Internet of Things (IoT) and artificial intelligence technologies. The Company's service offerings are configured and integrated with other platforms and enterprise applications.